Essential updates 2020/2021: Advancing precision medicine for comprehensive rectal cancer treatment

被引：11
作者：
Takemasa, Ichiro [1 ,3 ]
Hamabe, Atsushi [1 ,2 ]
Miyo, Masaaki [1 ]
Akizuki, Emi [1 ]
Okuya, Koichi [1 ]
机构：
[1] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, Sapporo, Japan
[2] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Osaka, Japan
[3] Sapporo Med Univ, Dept Surg Surg Oncol & Sci, S1 W16,Chuo Ku, Sapporo 0608543, Japan
来源：
ANNALS OF GASTROENTEROLOGICAL SURGERY | 2023年 / 7卷 / 02期
关键词：
diagnosis; multimodal therapy; rectal cancer; stratification; surgery; TOTAL MESORECTAL EXCISION; LOW ANTERIOR RESECTION; LYMPH-NODE DISSECTION; SITE LAPAROSCOPIC COLECTOMY; COMPLETE MESOCOLIC EXCISION; NEAR-INFRARED FLUORESCENCE; SYMPTOMATIC ANASTOMOTIC LEAKAGE; STAPLE LINE REINFORCEMENT; LONG-TERM OUTCOMES; OPEN D3 DISSECTION;
D O I：
10.1002/ags3.12646
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In the paradigm shift related to rectal cancer treatment, we have to understand a variety of new emerging topics to provide appropriate treatment for individual patients as precision medicine. However, information on surgery, genomic medicine, and pharmacotherapy is highly specialized and subdivided, creating a barrier to achieving thorough knowledge. In this review, we summarize the perspective for rectal cancer treatment and management from the current standard-of-care to the latest findings to help optimize treatment strategy.
引用
收藏
页码：198 / 215
页数：18
相关论文
共 23 条
  • [21] Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
    Yi-Ting Chen
    Tzu-Ting Tseng
    Hung-Pei Tsai
    Shih-Hsun Kuo
    Ming-Yii Huang
    Jaw-Yuan Wang
    Chee-Yin Chai
    Human Cell, 2022, 35 : 1912 - 1927
  • [22] Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine
    Chen, Yi-Ting
    Tseng, Tzu-Ting
    Tsai, Hung-Pei
    Kuo, Shih-Hsun
    Huang, Ming-Yii
    Wang, Jaw-Yuan
    Chai, Chee-Yin
    HUMAN CELL, 2022, 35 (06) : 1912 - 1927
  • [23] Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes
    Soomro, Misbah Younus
    Khan, Saqib Raza
    Muhammad, Hafiz
    Ahmad, Sujjawal
    Zehra, Nawazish
    Ali, Insia
    Samar, Mirza Rameez
    Hameed, Arif
    Moosajee, Munira
    Rashid, Yasmin Abdul
    BMC CANCER, 2024, 24 (01)
123